HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Anders Jeppsson Christopher G. A. McGregor Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pellegrini, C. Articles by McGregor, C. G. A. Search for Related Content PubMed PubMed Citation Articles by Pellegrini, C. Articles by McGregor, C. G. A.

J Thorac Cardiovasc Surg 2000;119:493-500
© 2000 Mosby, Inc.

CARDIOTHORACIC TRANSPLANTATION

HIGHLY EFFICIENT EX VIVO GENE TRANSFER TO THE TRANSPLANTED HEART BY MEANS OF HYPOTHERMIC PERFUSION WITH A LOW DOSE OF ADENOVIRAL VECTOR

From the Department of Surgery,^a Division of Endocrinology and Metabolism,^b Department of Physiology and Biophysics,^c and Department of Laboratory Medicine and Pathology,^d Mayo Clinic and Foundation, Rochester, Minn.

Supported by grants from the Mayo Clinic and Foundation, the Bruce and Ruth Rappaport Program in Vascular Biology, and HL58080 (T.O.B.). Dr Carlo Pellegrini is a visiting scientist supported in part by a grant from Associazione Ami.Cardio, Pavia, Italy.

Address for reprints: C. G. A. McGregor, MB, FRCS, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (E-mail: mcgregor.christopher{at}mayo.edu ).

Background: Hypothermic conditions required for donor heart preservation may reduce gene-transfer efficiency. Experiments were designed to determine whether a perfusion technique could improve the efficiency of gene transfer to donor hearts.
Methods: An adenoviral vector encoding ß-galactosidase (3.5 x 10⁸ plaque-forming units) was infused into explanted rat hearts under 4 conditions (each n = 6): (1) the virus was diluted in 350 µL of University of Wisconsin solution and infused as a high-pressure bolus into the coronary arteries of donor hearts through the aortic root; (2) the virus was diluted in 5 mL of University of Wisconsin solution and circulated by means of a peristaltic pump (flow, 0.75 mL/min) through the vasculature of the donor heart for 30 minutes; (3) 5 mL of viral solution was circulated as for group 2 for 15 minutes; and (4) 5 mL of viral solution was circulated for 5 minutes at a flow rate of 2.4 mL/min. Transduced hearts were transplanted into the abdomen of syngeneic rats, and transgene expression was assessed by means of immunoassay 4 days later.
Results: The median ß-galactosidase content was (1) 45.0 ng/mg protein (25th-75th percentile, 33-73 ng/mg), (2) 640 ng/mg protein (25th-75th percentile, 614-878 ng/mg), (3) 493.8 ng/mg protein (25th-75th percentile, 456-527 ng/mg), and (4) 503.3 ng/mg protein (25th-75th percentile, 475-562 ng/mg; P < .01 for group 2 vs group 1, and P < .05 for groups 3 and 4 vs group 1). Transgene expression was predominantly in myocytes and favored the subepicardial region of the right ventricle.
Conclusion: Hypothermic perfusion of the donor heart with an adenoviral vector resulted in efficient transgene expression compared with that induced by a single bolus injection.

This article has been cited by other articles:

				D. Ricci, A. A. Mennander, L. D. Pham, V. P. Rao, N. Miyagi, G. W. Byrne, S. J. Russell, and C. G.A. McGregor Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 32 - 39. [Abstract] [Full Text] [PDF]

				H. Abunasra, R. T. Smolenski, J. Yap, J. Jayakumar, M. Sheppard, and M. H. Yacoub Comparison of two gene transfer models for the attenuation of myocardial ischemia-reperfusion injury following preservation for cardiac transplantation. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 772 - 778. [Abstract] [Full Text] [PDF]

				Y. Qian, F.-L. Leong, A. Kazlauskas, and M. R. Dana Ex Vivo Adenovirus-Mediated Gene Transfer to Corneal Graft Endothelial Cells in Mice Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2187 - 2193. [Abstract] [Full Text] [PDF]

				H. J. Abunasra, R. T. Smolenski, J. Yap, M. Sheppard, T. O'Brien, and M. H. Yacoub Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 998 - 1006. [Abstract] [Full Text] [PDF]

				J. Yap, C. Pellegrini, T. O'Brien, H. D. Tazelaar, and C. G.A. McGregor Conditions of vector delivery improve efficiency of adenoviral-mediated gene transfer to the transplanted heart Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 702 - 707. [Abstract] [Full Text] [PDF]